These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23963152)

  • 21. Pancreatic contrast enhancement with Mn-bis pyridoxal ethylene diamine diacetic acid and the influence of a hormonal stimulation of the pancreas in pigs.
    Blume J; Palmié S; Aue B; Spielmann RP; Sievers E; Lodemann KP; Heller M
    Acad Radiol; 1994 Nov; 1(3):253-60. PubMed ID: 9419495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Focal liver lesions: MR imaging with Mn-DPDP--initial clinical results in 40 patients.
    Hamm B; Vogl TJ; Branding G; Schnell B; Taupitz M; Wolf KJ; Lissner J
    Radiology; 1992 Jan; 182(1):167-74. PubMed ID: 1309218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of manganese dipyridoxal diphosphate on liver magnetic resonance imaging and serum bilirubin in rats with removable biliary obstruction.
    Ni Y; Petré C; Lukito G; Marchal G; Grant D; Gray TJ; Baert AL
    Acad Radiol; 1995 Apr; 2(4):300-5. PubMed ID: 9419566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic enhancement after low-dose infusion of Mn-DPDP.
    Gehl HB; Vorwerk D; Klose KC; Günther RW
    Radiology; 1991 Aug; 180(2):337-9. PubMed ID: 1906189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [MR imaging of pancreatic lesions with Mn-DPDP. A histopathologic correlation].
    Dobritz M; Fellner FA; Baum U; Nömayr A; Lell M; Klein P; Papadopoulos T; Bautz W
    Rofo; 2002 Jul; 174(7):893-7. PubMed ID: 12101481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular effects of MnDPDP and MnCl2 in dogs with acute ischaemic heart failure.
    Karlsson JO; Mortensen E; Pedersen HK; Sager G; Refsum H
    Acta Radiol; 1997 Jul; 38(4 Pt 2):750-8. PubMed ID: 9245971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for the dissociation of the hepatobiliary MRI contrast agent Mn-DPDP.
    Gallez B; Bacic G; Swartz HM
    Magn Reson Med; 1996 Jan; 35(1):14-9. PubMed ID: 8771018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic resonance imaging of acute myocardial ischemia using a manganese chelate, Mn-DPDP.
    Pomeroy OH; Wendland M; Wagner S; Derugin N; Holt WW; Rocklage SM; Quay S; Higgins CB
    Invest Radiol; 1989 Jul; 24(7):531-6. PubMed ID: 2502502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mn-DPDP enhanced MRI in experimental bile duct obstruction.
    Marchal G; Ni Y; Zhang X; Yu J; Lodemann KP; Baert AL
    J Comput Assist Tomogr; 1993; 17(2):290-6. PubMed ID: 8454757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocellular tumors: characterization with Mn-DPDP-enhanced MR imaging.
    Rofsky NM; Weinreb JC; Bernardino ME; Young SW; Lee JK; Noz ME
    Radiology; 1993 Jul; 188(1):53-9. PubMed ID: 8390072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin II type 1 receptor antagonists prevent glucose-induced increases in islet blood flow in rats.
    Iwase M; Uchizono Y; Nohara S; Sasaki N; Sonoki K; Iida M
    Scand J Clin Lab Invest; 2009; 69(1):145-50. PubMed ID: 18937099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cirrhosis of the liver: MR imaging with mangafodipir trisodium (Mn-DPDP).
    Murakami T; Baron RL; Federle MP; Peterson MS; Oliver JH; Davis PL; Confer SR
    Radiology; 1996 Feb; 198(2):567-72. PubMed ID: 8596867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occlusive and reperfused myocardial infarcts: differentiation with Mn-DPDP--enhanced MR imaging.
    Saeed M; Wagner S; Wendland MF; Derugin N; Finkbeiner WE; Higgins CB
    Radiology; 1989 Jul; 172(1):59-64. PubMed ID: 2500678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP).
    Murakami T; Baron RL; Peterson MS; Oliver JH; Davis PL; Confer SR; Federle MP
    Radiology; 1996 Jul; 200(1):69-77. PubMed ID: 8657947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contrast-enhanced magnetic resonance imaging of the liver with Mn-DPDP for known or suspected focal hepatic disease.
    Bernardino ME; Young SW; Lee JK; Weinreb J
    Invest Radiol; 1991 Nov; 26 Suppl 1():S148-9; discussion S150-5. PubMed ID: 1808113
    [No Abstract]   [Full Text] [Related]  

  • 36. The uptake of Mn-DPDP by hepatocytes is not mediated by the facilitated transport of pyridoxine.
    Gallez B; Baudelet C; Adline J; Charbon V; Lambert DM
    Magn Reson Imaging; 1996; 14(10):1191-5. PubMed ID: 9065910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A segmental hyperintensity area in the liver shown by delayed MR images with Mn-DPDP.
    Suto Y; Weinreb JC; Rofski NM
    J Comput Assist Tomogr; 1996; 20(4):647-9. PubMed ID: 8708073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac natriuretic peptides and pancreatic islet blood flow in anesthetized rats.
    Carlsson PO; Andersson A; Jansson L
    Horm Metab Res; 2001 Mar; 33(3):181-5. PubMed ID: 11355754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of contrast enhanced CT and Mn-DPDP enhanced MRI for detection of focal hepatic lesions. Initial findings.
    Birnbaum BA; Weinreb JC; Fernandez MP; Brown JJ; Rofsky NM; Young SW
    Clin Imaging; 1994; 18(1):21-7. PubMed ID: 8180855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MRI for detection of hepatocellular carcinoma: comparison of mangafodipir trisodium and gadopentetate dimeglumine contrast agents.
    Youk JH; Lee JM; Kim CS
    AJR Am J Roentgenol; 2004 Oct; 183(4):1049-54. PubMed ID: 15385303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.